Annual meeting canceled amid global viral outbreak.
The announcement came Thursday that HIMSS will cancel its 2020 Global Health Conference & Exhibition. The decision comes on the tail of recent reports from the World Health Organization and Centers for Disease Control & Prevention on the spread and impact of COVID-19.
As of yet, no rescheduling information has been released. But, according to the organization, a lack of suitable venues and the difficulty in coordinating speaker and exhibitor availabilities make it unlikely that the conference will be rescheduled for later this year.
HIMSS officials cited an increased understanding of the potential spread of the virus over the past 24 hours, as well as the unique medical profile of conference attendees as underlying reasons to cancel. With these factors in play, they said, it isn’t currently possible to fully assess the risks posed to participants, and continuing as planned could have placed undo stress on the local health system in Orlando.
This will be the first time in 58 years HIMSS will have canceled the event, and Hal Wolf, HIMSS president and CEO acknowledged all the effort behind planning the conference until this point.
“We recognize all the hard work that so many have put into preparing for their presentations and panels that accompany every HIMSS conference,” he said. “Based on evaluation of evolving circumstances and coordination with an external advisory panel of medical professional to support evidence-based decision making it is clear that it would be an unacceptable risk to bring so many thousands of people together in Orlando next week.”
HIMSS officials have posted additional information about travel and registration reimbursements on its website.
What New Research Reveals About Novice Use of AI-Guided Cardiac Ultrasound
April 4th 2025In a study recently presented at the American College of Cardiology (ACC) conference, researchers found that novice use of AI-guided cardiac ultrasound after an AI-enabled electrocardiogram increased the positive predictive value for reduced left ventricular ejection fraction (LVEF) or aortic valve stenosis by 33 percent.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.